Nath Bio-Genes (India) Limited
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Nath Bio-Genes (India) Limited's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 11% to $2,475,260,000. The net income raised on $396,185,000 and profit margin reached 16%. Total operating expenses were $554,123,000.

Profit Margin

Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN.NS): Profit margin
2012 1.23B 92.00M 7.42%
2015 1.85B 253.97M 13.7%
2016 1.62B 141.67M 8.74%
2018 1.91B 294.18M 15.35%
2019 2.30B 384.33M 16.67%
2021 3.07B 556.61M 18.11%
2022 2.78B -673.38M -24.19%
2024 2.47B 396.18M 16.01%

NATHBIOGEN.NS Income Statement (2012 – 2023)

2023 2021 2020 2018 2017 2015 2014 2012
Revenue
Revenue
2.47B2.78B3.07B2.30B1.91B1.62B1.85B1.23B
Cost of revenue
1.44B1.23B1.36B1.07B848.36M545.34M582.36M503.42M
Gross profit
1.03B1.54B1.71B1.22B1.06B1.07B1.27B735.72M
Operating exp.
Research and development
112.76M88.85M91.54M25.69M78.78M111.16M122.29M71.90M
Selling and marketing
276.36M198.14M212.00M178.10M119.05M139.99M142.37M365.80M
Total operating expenses
554.12M1.19B1.06B804.23M652.97M861.16M965.92M613.69M
Operating income
477.02M345.69M643.36M419.91M414.99M214.54M304.98M122.02M
Other income (expenses), net
-61.37M-980.03M-84.84M-31.23M-99.73M-55.20M-41.45M-31.27M
Income before tax
415.64M-633.9M567.51M388.68M300.54M152.15M263.52M90.75M
Income tax expense
19.46M39.51M10.89M4.34M6.35M10.48M9.55M-1.25M
Net income
396.18M-673.38M556.61M384.33M294.18M141.67M253.97M92.00M
Earnings per share
Basic EPS
20.85-35.4329.2920.2217.838.8515.875.75
Diluted EPS
20.85-35.4329.2920.2217.318.8515.875.75
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData source